{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:43:50Z","timestamp":1792676630390,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T00:00:00Z","timestamp":1388102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0084634","type":"journal-article","created":{"date-parts":[[2013,12,27]],"date-time":"2013-12-27T21:50:00Z","timestamp":1388181000000},"page":"e84634","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":91,"title":["Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor 7, 8, and 9 Antagonists in a Model of IL-23-Induced Skin Inflammation"],"prefix":"10.1371","volume":"8","author":[{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca S.","family":"Ortenzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"BJ Nickoloff","year":"2004","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"P Di Meglio","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris","volume":"102","author":"F Chamian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0509736102","article-title":"Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)","volume":"102","author":"MA Lowes","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"MA Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","article-title":"Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses","volume":"204","author":"LC Zaba","year":"2007","journal-title":"J Exp Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/jid.2009.59","article-title":"The IL-23\/Th17 axis in the immunopathogenesis of psoriasis","volume":"129","author":"A Di Cesare","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"JG Krueger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"LE Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"M Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","article-title":"IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways","volume":"173","author":"CY Kao","year":"2004","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.20061308","article-title":"Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides","volume":"203","author":"SC Liang","year":"2006","journal-title":"J Exp Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris","volume":"199","author":"E Lee","year":"2004","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"G Piskin","year":"2006","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"MA Lowes","year":"2013","journal-title":"Trends Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4049\/jimmunol.1001001","article-title":"IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A","volume":"186","author":"HL Rizzo","year":"2011","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1084\/jem.20060244","article-title":"IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis","volume":"203","author":"JR Chan","year":"2006","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e18266","DOI":"10.1371\/journal.pone.0018266","article-title":"Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis","volume":"6","author":"WR Swindell","year":"2011","journal-title":"PLOS ONE"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1172\/JCI119766","article-title":"Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype","volume":"100","author":"PW Cook","year":"1997","journal-title":"J Clin Invest"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nm1162","article-title":"Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model","volume":"11","author":"S Sano","year":"2005","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2353\/ajpath.2009.080858","article-title":"Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis","volume":"174","author":"JA Wolfram","year":"2009","journal-title":"Am J Pathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/sj.emboj.7600183","article-title":"Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder","volume":"23","author":"AG Li","year":"2004","journal-title":"EMBO J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"L van der Fits","year":"2009","journal-title":"J Immunol"},{"key":"ref24","article-title":"A Toll-Like Receptor 7, 8 and 9 Antagonist Inhibits Th1 and Th17 Responses and Inflammasomes Activation in a Model of IL-23-Induced Psoriasis","author":"W Jiang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"ref25","first-page":"S26","article-title":"IMO-3100, an antagonist of Toll-like receptor (TLR) 7 and TLR9, demonstrates clinical activity in psoriasis patients with 4 weeks of treatment in a phase 2a trial International Investigative Dermatology Meeting. Edinburgh, Scotland","author":"AB Kimball","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"T Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"ref27","first-page":"3651","article-title":"TLR8 deficiency leads to autoimmunity in mice","volume":"120","author":"O Demaria","year":"2010","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20090480","article-title":"Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8","volume":"206","author":"D Ganguly","year":"2009","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"R Lande","year":"2007","journal-title":"Nature"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.intimp.2012.04.003","article-title":"Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle","volume":"13","author":"A Farkas","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4049\/jimmunol.1202225","article-title":"TLR9-dependent IL-23\/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis","volume":"190","author":"U Bhan","year":"2013","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"L Tortola","year":"2012","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.4049\/jimmunol.1000733","article-title":"Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation","volume":"185","author":"NW Lukacs","year":"2010","journal-title":"J Immunol"},{"key":"ref34","first-page":"670","article-title":"Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism","volume":"164","author":"U Patel","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref35","first-page":"2010","article-title":"Toll-like receptors: role in dermatological disease","author":"A Hari","year":"2010","journal-title":"Mediators Inflamm"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e44274","DOI":"10.1371\/journal.pone.0044274","article-title":"Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease","volume":"7","author":"S Tian","year":"2012","journal-title":"PLOS ONE"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1038\/jid.2010.36","article-title":"Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models","volume":"130","author":"JE Gudjonsson","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e10247","DOI":"10.1371\/journal.pone.0010247","article-title":"Evaluation of the psoriasis transcriptome across different studies by gene set enrichment analysis (GSEA)","volume":"5","author":"M Su\u00e1rez-Fari\u00f1as","year":"2010","journal-title":"PLOS ONE"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"M Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e2737","DOI":"10.1371\/journal.pone.0002737","article-title":"Type I interferon: potential therapeutic target for psoriasis?","volume":"3","author":"Y Yao","year":"2008","journal-title":"PLOS ONE"},{"key":"ref41","first-page":"185","article-title":"Type I Interferons in Psoriasis","year":"2013"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"M Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2796.2008.02050.x","article-title":"Signalling pathways leading to IFN-alpha production in human plasmacytoid dendritic cell and the possible use of agonists or antagonists of TLR7 and TLR9 in clinical indications","volume":"265","author":"C Guiducci","year":"2009","journal-title":"J Intern Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"N Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/jid.2008.194","article-title":"Psoriasis is characterized by accumulation of immunostimulatory and Th1\/Th17 cell-polarizing myeloid dendritic cells","volume":"129","author":"LC Zaba","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref46","first-page":"3","article-title":"Human keratinocytes express functional Toll-like receptor","author":"MC Lebre","year":"2007"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"S Morizane","year":"2012","journal-title":"J Dermatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: rationale for targeting interleukin-17","volume":"167","author":"G Girolomoni","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1021\/jm8014316","article-title":"Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9","volume":"52","author":"D Wang","year":"2009","journal-title":"J Med Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1021\/jm900730r","article-title":"Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9","volume":"52","author":"D Yu","year":"2009","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/1471-2105-6-294","article-title":"Harshlight: a "corrective make-up" program for microarray chips","volume":"6","author":"M Su\u00e1rez-Fari\u00f1as","year":"2005","journal-title":"BMC Bioinformatics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/jid.2009.173","article-title":"Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin","volume":"129","author":"JE Gudjonsson","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/jid.2011.267","article-title":"Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes","volume":"132","author":"A Jabbari","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physiolgenomics.00157.2002","article-title":"Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array","volume":"13","author":"X Zhou","year":"2003","journal-title":"Physiol Genomics"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/jid.2011.348","article-title":"A subset of methylated CpG sites differentiate psoriatic from normal skin","volume":"132","author":"ED Roberson","year":"2012","journal-title":"J Invest Dermatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0084634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:48:32Z","timestamp":1589017712000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0084634"}},"subtitle":[],"editor":[{"given":"Deyu","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,27]]},"references-count":55,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0084634","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,27]]}}}